Table 1.
Patients were mildly ataxic and in a stable condition (>5 yr postoperative)
| Adjuvant Therapies |
ICARS |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Age, yr | Time Postop, yr | Sex, M/F | Diagnosis | Interposed Nuclei Lesioned | RT | CT | Lesion Volume, cm3 | Total/100 | P&G/34 | Kin Funct/52 |
| 1 | 28.8 | 13.9 | F | Lhermitte-Duclos disease | 58.0 | 3 | 1 | 1 | |||
| 2 | 20.2 | 8.7 | F | Pilocytic astrocytoma | 8.2 | 3 | 0 | 0 | |||
| 3 | 19.6 | 11.8 | M | Pilocytic astrocytoma | Left | 1.7 | 6 | 3 | 2 | ||
| 4 | 18.1 | 6.5 | F | Pilocytic astrocytoma | 4.5 | 1 | 0 | 1 | |||
| 5 | 22.3 | 17.7 | M | Medulloblastoma | Both | Y | 22.0 | 13 | 6 | 2 | |
| 6 | 18.5 | 10.0 | F | Medulloblastoma | Left | Y | Y | 22.6 | 2 | 1 | 1 |
| 7 | 18.6 | 13.7 | M | Medulloblastoma | Right | Y | Y | 6.3 | 19 | 5 | 10 |
| 8 | 18.4 | 15.5 | F | Medulloblastoma | Both | Y | Y | 5.4 | 5 | 1 | 3 |
| 9 | 39.9 | 30.2 | F | Hemangioblastoma | No MRI | Y | 6 | 4 | 2 | ||
| 10 | 20.5 | 13.1 | F | Pilocytic astrocytoma | 36.3 | 2 | 1 | 0 | |||
| 11 | 19.0 | 5.7 | M | Pilocytic astrocytoma | Right | 15.7 | 7 | 2 | 5 | ||
| 12 | 22.0 | 18.7 | M | Astrocytoma grade II | 2.0 | 1 | 0 | 1 | |||
| 13 | 21.6 | 19.5 | F | Astrocytoma grade II | Right | Y | 7.1 | 0 | 0 | 0 | |
| 14 | 26.9 | 24.9 | F | Pilocytic astrocytoma | Y | 58.4 | 5 | 1 | 1 | ||
| 15 | 31.3 | 18.2 | F | Medulloblastoma | Both | Y | Y | 14.2 | 17 | 10 | 4 |
For patient 9 no MRI data were acquired.
Postop, postoperative; F, female; M, male; RT, radiotherapy; CT, chemotherapy; Y, yes; ICARS, International Cooperative Ataxia Rating Scale; P&G, posture and gait subscore; Kin Funct, kinetic functions subscore.